Benzoic-D5 acid as D2 receptor agonist in the treatment of rotenone induced Parkinson’s disease in mice-Reference-Cited by-同舟云学术

Benzoic-D5 acid as D2 receptor agonist in the treatment of rotenone induced Parkinson’s disease in mice

Published:2023-08 Issue:8 Volume:16 Page:104982
ISSN:1878-5352
Container-title:Arabian Journal of Chemistry
language:en
Short-container-title:Arabian Journal of Chemistry

Author:

Awais Ali Zaidi Syed,Ahmad Khan Mahtab,Rizwan Khan Muhammad,Ahmed Hammad,Ali Shahryar Zaib,Umar Khayam Sahibzada Muhammad,Alghamdi Saad,Aljuaid Abdulelah,Almehmadi Mazen,Allahyani Mamdouh

Funder

Taif University

Deanship of Scientific Research, King Saud University

Publisher

Elsevier BV

Subject

General Chemical Engineering,General Chemistry

Reference62 articles.

1. Acacia modesta attenuates MnCl2 induced hepatotoxicity, oxidative stress and hepatic inflammation in wistar rats;Abid;Pak. J. Pharm. Sci.,2021

2. In silico ADME-Tox modeling: progress and prospects;Alqahtani;Expert Opin. Drug Metab. Toxicol.,2017

3. Europinidin Inhibits Rotenone-Activated Parkinson’s Disease in Rodents by Decreasing Lipid Peroxidation and Inflammatory Cytokines Pathways;Altharawi;Molecules,2022

4. Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities;Angelopoulou;J. Biochem. Mol. Toxicol.,2021

5. Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design;Athar;J. Biomol. Struct. Dyn.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Neuroprotective Effect of Gut Microbe in Parkinson's Disease: An In Silico and In Vivo Approach;NeuroMolecular Medicine;2024-08-01

2. Pharmacological Assessment of Aqueous Ethanolic Extract of Thalictrum Foetidum Against Haloperidol-Induced Parkinson’s Like Symptoms in Animal Model: A Dose-Dependent Study With Mechanistic Approach;Dose-Response;2024-07